Vital Therapies (VTL) Tops Q4 EPS by 8c

Vital Therapies (NASDAQ: VTL) reported Q4 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c